Several studies have shown that cooling the scalp to a very low temperature can help reduce hair loss due to chemotherapy treatment for breast cancer. In this podcast, Julie Nangia, M.D., assistant professor of medicine, Baylor College of Medicine talks about the study results she presented at the 2016 San Antonio Breast Cancer Symposium on the Orbis Paxman Hair Loss Prevention System. The study was the first prospective, randomized trial on a scalp cooling system and found that about 50% of the women who used the cooling system kept most of their hair. Listen to the podcast to hear Dr. Nangia explain: how the Paxman Hair Loss Preservation System works how the type of chemotherapy regimen the women were on affected the results why doing a prospective, randomized trial was important Editor’s Note: On April 19, 2017, the Paxman Scalp Cooling System received U.S. Food and Drug Administration clearance. This means the system can be marketed in the United States.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related